Collier William H. 4
4 · Arbutus Biopharma Corp · Filed Jan 20, 2022
Insider Transaction Report
Form 4
Collier William H.
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2022-01-20$2.81/sh+787,550$2,213,016→ 787,550 totalExercise: $2.81Exp: 2032-01-20→ Common Shares (787,550 underlying)
Footnotes (1)
- [F1]These stock options will vest and become exercisable 1/48th each month over the four year period.